Loading clinical trials...
Loading clinical trials...
This project aims to provide the proof of concept for transcranial direct-current stimulation (tDCS) in the treatment of resistant/persistent Schizophrenia symptoms. The purpose is to investigate the ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospices Civils de Lyon
NCT06455384 · Cardiac Conditions, Connective Tissue Diseases, and more
NCT07565428 · Negative Symptoms of Schizophrenia
NCT07645443 · Early Onset Psychosis, First Psychotic Episode Within the Last 5 Years, and more
NCT06257056 · Treatment-Refractory Schizophrenia
NCT07288333 · Schizophrenia
Centre Hospitalier Le Vinatier - Service de Psychiatrie Adulte
Bron
Centre Esquirol - CHU de Caen - Service de Psychiatrie Adulte,
Caen
CHU de Clermont-Ferrand - Pôle de Psychiatrie B
Clermont-Ferrand
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions